A 58-year-old man with type 2 diabetes and coronary artery disease has an A1c of 8.2% despite maximally tolerated metformin. eGFR is 70 mL/min/1.73 m²...

Question

A 58-year-old man with type 2 diabetes and coronary artery disease has an A1c of 8.2% despite maximally tolerated metformin. eGFR is 70 mL/min/1.73 m². Which additional agent is preferred to improve both glycemic control and cardiovascular outcomes?

Accepted Answer

SGLT2 inhibitor

Answer

Sulfonylurea

Answer

DPP-4 inhibitor

Answer

Alpha-glucosidase inhibitor

Answer

Meglitinide

us-abfm MCQ (SBA): Type 2 Diabetes Mellitus with ASCVD

A 58-year-old man with type 2 diabetes and coronary artery disease has an A1c of 8.2% despite maximally tolerated metformin. eGFR is 70 mL/min/1.73 m². Which additional agent is preferred to improve both glycemic control and cardiovascular outcomes?